Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of two 500 mg levetiracetam tablet formulations in healthy Thai adults under fasting conditions
TCTR20200123001Phase 1Not yet recruiting
- Sponsor
- T.O. Chemicals
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of levetiracetam (2 arms), sponsored by T.O. Chemicals. Primary endpoints: Plasma levetiracetam concentration, AUC0-t and 4 more. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
levetiracetam
Beyond the preview
Go deeper on TCTR20200123001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200123001.